Menopause and heart health: Understanding the risks

Written in association with: Dr Gosia Wamil
Published:
Edited by: Kate Forristal

Menopause signifies a significant life transition for women, typically occurring between the ages of 45 and 55. As women age and approach menopause, their susceptibility to heart disease increases due to the decline in oestrogen levels. This hormonal shift, often overlooked in cardiovascular research, exposes women to a heightened risk of cardiovascular disease (CVD). In her latest online article, Dr Gosia Wamil delves into the impact of menopause on heart health, drawing insights from key research findings and shedding light on the importance of gender-specific considerations in cardiovascular care.

Research findings: 

  • American Heart Association (AHA) heart disease and stroke statistics (2021): The AHA highlights a substantial increase in the risk of heart disease in women following menopause, reaching levels nearly equivalent to those observed in men. Shockingly, cardiovascular disease is identified as the leading cause of death in women, contributing to approximately one in three female fatalities.

 

  • The Framingham heart study: This influential epidemiological investigation accentuates a significant elevation in the risk of coronary heart disease for both men and women after the age of 55. Postmenopausal women appear to "catch up" to men concerning heart disease risk during this crucial phase of life.

 

  • Atherosclerosis risk in communities (ARIC) Study: The ARIC study further strengthens the argument by revealing a comparable incidence of coronary heart disease in postmenopausal women and men. This highlights the profound influence of menopause-associated hormonal changes on heart disease risk.

 

  • A meta-analysis of prospective cohort studies: A meta-analysis conclusively establishes that postmenopausal women confront a comparable risk of developing coronary heart disease to that of men. This emphasises the urgent need to address cardiovascular risk factors specifically in postmenopausal women.

 

Oestrogen’s role in heart health:

Oestrogen, a cornerstone in fortifying heart health among women, contributes to sustaining optimal cholesterol levels, fostering vasodilation, and exerting anti-inflammatory effects on arterial linings. Additionally, oestrogen promotes improved blood circulation and hinders arterial plaque accumulation. However, as women transition through menopause and oestrogen levels decline, these protective effects diminish, leading to heightened risks of hypertension, elevated cholesterol, and an increased susceptibility to heart disease.

 

Cholesterol regulation:

The primary mechanism by which oestrogen protects heart health lies in its regulation of cholesterol. Through interaction with the liver, oestrogen orchestrates an overall reduction in total cholesterol levels while elevating high-density lipoprotein (HDL) cholesterol (the "good" cholesterol) and reducing low-density lipoprotein (LDL) cholesterol (the "bad" cholesterol).

 

Gender bias in cardiovascular research:

Historically, cardiovascular research and clinical guidelines have predominantly focused on male populations, inadvertently creating a gender bias in understanding symptoms and risk factors related to cardiovascular disease (CVD). This oversight has led to the underestimation or even overlooking of manifestations of CVD in women. Recognising the impact of hormonal fluctuations, especially during menopause, is imperative for precise diagnosis, timely intervention, and the development of appropriate prevention and treatment strategies for cardiovascular disease in women.

 

Atypical symptoms in women:

Women may exhibit atypical or less pronounced symptoms compared to men, necessitating a more nuanced approach in diagnosis. Symptoms such as fatigue, shortness of breath, nausea, vomiting, or pain in the neck, jaw, upper back, or abdomen may indicate cardiovascular issues. Women typically experience cardiovascular events about a decade later than men, owing to the protective effects of oestrogen before menopause.

 

Dr Gosia Wamil is an esteemed cardiologist with over 20 years of experience. You can schedule an appointment with Dr Wamil on her Top Doctors profile.

By Dr Gosia Wamil
Cardiology

Dr Malgorzata (Gosia) Wamil, PhD is an Oxford-trained, internationally recognised consultant cardiologist. She practices at the world-renowned Mayo Clinic Healthcare in London and the Manor Hospital in Oxford. Her clinical specialities are heart failure and the precise application of non-invasive cardiac imaging techniques, including cardiovascular MRIcardiac CT, and advanced echocardiography (trans-oesophageal echocardiography, bubble echocardiography, contrast echocardiography, 3D echocardiography, and stress echo).
 
Dr Wamil’s extensive expertise has been honed through years of dedicated practice and specialized training, with patients frequently asking her for a second opinion. Dr Wamil pursued comprehensive cardiology training at the Oxford University Hospitals between 2008 and 2017. This rigorous program encompassed fellowships in cardiovascular medicine, advanced cardiac imaging, heart failure and cardiomyopathies. During this period, Dr. Wamil earned internationally recognised accreditations in echocardiography, cardiac CT, and cardiac magnetic resonance, showcasing her commitment to excellence. She has received multiple awards for her academic excellence, including fellowships and grants from esteemed organizations like the British Heart Foundation, the European Association of Cardiovascular Imaging and the European Society of Cardiology.
 
Acknowledged for her academic excellence, Dr. Wamil has been honoured with multiple awards, fellowships, and grants from esteemed organizations such as the British Heart Foundation, the European Association of Cardiovascular Imaging, and the European Society of Cardiology. Her research journey spans the spectrum, from fundamental science and drug development (MSc and PhD in Cardiovascular Science, University of Edinburgh 2005-2008), to pioneering proof-of-concept studies employing imaging techniques (British Heart Foundation Postdoctoral Fellowship at the University of Oxford 2016-2017) and randomized clinical trials (MSc in Clinical Trials, University of Oxford 2022-2024).

Dr. Wamil is known for her cardiac MRI, CT, and advanced echocardiography expertise and is often able to combine them in ways that are transformational in the treatment of complex cardiovascular cases. Actively participating in the European Association of Cardiovascular Imaging, she holds a distinguished role as a member of the prestigious Leaders of Tomorrow Programme. This involvement allows her to be pivotal in organizing international teaching courses and setting standards for operating cardiac imaging departments across Europe. Her dedication to education extends to imparting knowledge and expertise to aspiring medical students and junior doctors through diverse teaching platforms and programs. 
 
In her clinical practice, Dr. Wamil excels with a uniquely effective human-centric and holistic approach to medicine with patients. Her expertise, however, extends well beyond the hands-on practice.
 
She holds the esteemed position of Honorary Senior Researcher Fellow in the Deep Medicine Department at the University of Oxford, actively contributing to ground-breaking research. As a Diabetes Pharma Committee Member at the National Institute for Health and Care Excellence (NICE), she co-authored national guidelines for managing heart disease in people with diabetes. In recognition of Dr. Wamil's scientific contribution, she holds the title of Fellow of the European Society of Cardiology and is a member of several medical organisations such as the Royal College of Physicians, British Society of Echocardiography, and European Society of Cardiovascular Imaging and the European Heart Association.
 
 

View Profile

Overall assessment of their patients


  • Related procedures
  • Heart attack
    Arrhythmia
    Hypertension (high blood pressure)
    Pericarditis
    Heart failure
    Injury valves
    Heart murmur
    Echocardiogram
    Electrocardiogram
    Ambulatory electrocardiogram (Holter)
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.